Apni Pathshala

Daily Current Affairs English

India-Japan Forum 2024

India-Japan Forum 2024

Why in News? The India-Japan Forum 2024 focuses on the growing strategic cooperation between India and Japan, especially in the area of semiconductors. Indian External Affairs Minister S. Jaishankar highlighted the potential of a strategic semiconductor alliance between the two nations.  India and Japan are working together to strengthen their semiconductor industries and make global […]

India-Japan Forum 2024 Read More »

Syrian Civil War

Syrian Civil War

Why in News? Syria’s civil war has entered a new phase with a sudden attack by the military opposition command on forces loyal to President Bashar al-Assad. They have taken control of major cities, including Aleppo, Hama, Homs, and Daraa. The political situation in Syria has become more uncertain. Introduction of Syrian Civil War: The

Syrian Civil War Read More »

Golan heights

Israel Takes Control of Golan Heights Buffer Zone

Why in News? In a significant move amid ongoing unrest in Syria, Israel has expanded its control over the Golan Heights. On December 8, 2024, Israeli Prime Minister Benjamin Netanyahu announced that the Israeli Defense Forces (IDF) have deployed military forces in a newly established buffer zone along the Golan Heights.  Introduction to the Golan

Israel Takes Control of Golan Heights Buffer Zone Read More »

Bharatiya Vayuyan Vidheyak, 2024

Bharatiya Vayuyan Vidheyak, 2024

Why in News? The Bharatiya Vayuyan Vidheyak, 2024, passed by the Indian Parliament, aims to modernize and address contemporary challenges in the civil aviation sector, replacing the Aircraft Act, 1934.  Highlights of the Bharatiya Vayuyan Vidheyak, 2024: Authorities and Oversight: Establishes three key aviation bodies: Directorate General of Civil Aviation (DGCA) for regulatory and safety

Bharatiya Vayuyan Vidheyak, 2024 Read More »

India’s First Indigenous Antibiotic: Nafithromycin

Why in News? India has launched its first indigenous antibiotic, Nafithromycin. It is a significant milestone in the fight against antimicrobial resistance (AMR). This drug is designed to treat infections caused by drug-resistant bacteria, particularly community-acquired bacterial pneumonia (CABP), and aims to tackle the global health emergency of antimicrobial resistance. Key Highlights of Nafithromycin Launch:

India’s First Indigenous Antibiotic: Nafithromycin Read More »

Scroll to Top